Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents (Note 7)	$ 2,290.2	$ 7,320.7
Short-term investments (Note 7)	77.7	88.2
Accounts receivable, net of allowances of $23.7 (2019) and $24.1 (2018)	4,612.5	4,593.9
Other receivables	977.5	1,182.9
Inventories	3,181.1	3,098.1
Prepaid expenses and other	2,315.5	2,036.7
Current assets of discontinued operations (Note 5)	0.0	2,229.1
Total current assets	13,454.5	20,549.6
Investments (Note 7)	1,852.7	2,005.4
Goodwill	3,820.1	1,366.6
Other intangibles, net	6,586.6	1,068.0
Deferred tax assets	2,507.4	2,613.7
Sundry	2,052.1	1,824.9
Property and equipment, net of accumulated depreciation of $8,956.3 (2019) and $8,666.9 (2018)	7,847.5	7,996.1
Operating lease assets (Note 8)	545.5	0.0
Noncurrent assets of discontinued operations (Note 5)	0.0	6,484.1
Total assets	38,666.4	43,908.4
Current Liabilities
Short-term borrowings and current maturities of long-term debt	2,068.6	1,102.2
Accounts payable	1,198.9	1,207.1
Employee compensation	588.2	955.6
Sales rebates and discounts	4,993.7	4,849.5
Dividends payable	593.9	650.8
Income taxes payable	222.9	393.4
Other current liabilities	2,189.2	2,036.7
Current liabilities of discontinued operations (Note 5)	0.0	692.8
Total current liabilities	11,855.4	11,888.1
Other Liabilities
Long-term debt	13,717.6	9,196.4
Noncurrent operating lease liabilities (Note 8)	503.3	0.0
Accrued retirement benefits (Note 10)	2,723.4	2,802.2
Long-term income taxes payable	3,485.7	3,700.0
Deferred tax liabilities	2,380.9	1,312.7
Other noncurrent liabilities	1,142.8	1,357.6
Noncurrent liabilities of discontinued operations (Note 5)	0.0	2,742.3
Total other liabilities	23,953.7	21,111.2
Commitments and Contingencies (Note 11)
Eli Lilly and Company Shareholders’ Equity
Common stock	603.7	661.0
Additional paid-in capital	6,534.5	6,583.6
Retained earnings	4,318.1	11,395.9
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss (Note 12)	(5,600.5)	(5,729.2)
Cost of common stock in treasury	(62.1)	(69.4)
Total Eli Lilly and Company shareholders’ equity	2,780.5	9,828.7
Noncontrolling interests	76.8	1,080.4
Total equity	2,857.3	10,909.1
Total liabilities and equity	$ 38,666.4	$ 43,908.4